BLTE BELITE BIO, INC
Healthcare · Pharmaceutical Preparations · Market cap: $6.5B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $8.5M |
| 2026-Q3 | $0 | $32.0M |
| 2026-Q4 | $0 | $82.7K |
Bought$00 buy days
Sold$40.6M29 sell days
Net insider flow-$40.6Mnet selling · 5 years
Latest trade2026-10-01Scholl Hendrik Peter
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Sell | Scholl Hendrik Peter | Other C-suite | 500 | $165.32 | $82.7K | 8 |
| 2026-09-08 | Sell | Lin Yu-Hsin | CEO | 26,000 | $196.56 | $5.1M | 5 |
| 2026-09-08 | Sell | Chuang Hao-Yuan | CFO | 17,962 | $196.42 | $3.5M | 5 |
| 2026-09-04 | Sell | Lin Yu-Hsin | CEO | 74,435 | $187.71 | $14.0M | 14 |
| 2026-09-04 | Sell | Chuang Hao-Yuan | CFO | 49,433 | $187.64 | $9.3M | 14 |
| 2026-08-12 | Sell | Chuang Hao-Yuan | CFO | 367 | $180.35 | $66.2K | 2 |
| 2026-08-12 | Sell | Lin Yu-Hsin | CEO | 365 | $180.35 | $65.8K | 2 |
| 2026-06-18 | Sell | Scholl Hendrik Peter | Other C-suite | 10,000 | $145.24 | $1.5M | 5 |
| 2026-06-16 | Sell | Scholl Hendrik Peter | Other C-suite | 10,000 | $140.57 | $1.4M | 8 |
| 2026-05-07 | Sell | MATA NATHAN L. | Other C-suite | 666 | $153.21 | $102.0K | 4 |
| 2026-05-06 | Sell | MATA NATHAN L. | Other C-suite | 1,000 | $153.84 | $153.8K | 6 |
| 2026-05-05 | Sell | MATA NATHAN L. | Other C-suite | 1,000 | $155.50 | $155.5K | 6 |
| 2026-05-04 | Sell | MATA NATHAN L. | Other C-suite | 1,000 | $155.64 | $155.6K | 5 |
| 2026-05-01 | Sell | MATA NATHAN L. | Other C-suite | 1,000 | $155.78 | $155.8K | 8 |
| 2026-04-30 | Sell | MATA NATHAN L. | Other C-suite | 1,000 | $156.97 | $157.0K | 4 |
| 2026-04-29 | Sell | MATA NATHAN L. | Other C-suite | 1,000 | $155.82 | $155.8K | 5 |
| 2026-04-28 | Sell | MATA NATHAN L. | Other C-suite | 1,000 | $159.16 | $159.2K | 9 |
| 2026-04-27 | Sell | MATA NATHAN L. | Other C-suite | 1,000 | $162.64 | $162.6K | 5 |
| 2026-04-24 | Sell | MATA NATHAN L. | Other C-suite | 1,000 | $159.56 | $159.6K | 6 |
| 2026-04-23 | Sell | MATA NATHAN L. | Other C-suite | 1,000 | $166.28 | $166.3K | 6 |
| 2026-04-22 | Sell | MATA NATHAN L. | Other C-suite | 1,000 | $170.39 | $170.4K | 9 |
| 2026-04-21 | Sell | MATA NATHAN L. | Other C-suite | 1,000 | $166.00 | $166.0K | 5 |
| 2026-04-20 | Sell | MATA NATHAN L. | Other C-suite | 1,000 | $163.60 | $163.6K | 7 |
| 2026-04-17 | Sell | MATA NATHAN L. | Other C-suite | 1,000 | $161.63 | $161.6K | 6 |
| 2026-04-16 | Sell | MATA NATHAN L. | Other C-suite | 1,000 | $160.38 | $160.4K | 7 |
| 2026-04-15 | Sell | MATA NATHAN L. | Other C-suite | 1,000 | $168.30 | $168.3K | 5 |
| 2026-04-09 | Sell | Lin Yu-Hsin | CEO | 9,200 | $181.45 | $1.7M | 4 |
| 2026-04-09 | Sell | Chuang Hao-Yuan | CFO | 6,200 | $181.50 | $1.1M | 4 |
| 2026-04-09 | Sell | Chen Wan-Shan | Director | 1,100 | $180.43 | $198.5K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Lin Yu-Hsin | CEO | $0 | $20.8M | 2026-09-08 |
| Chuang Hao-Yuan | CFO | $0 | $14.0M | 2026-09-08 |
| Scholl Hendrik Peter | Other C-suite | $0 | $2.9M | 2026-10-01 |
| MATA NATHAN L. | Other C-suite | $0 | $2.7M | 2026-05-07 |
| Chen Wan-Shan | Director | $0 | $198.5K | 2026-04-09 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.